NeuroPace, Inc.
NPCE
$16.36
-$0.14-0.85%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.99M | -25.94M | -24.81M | -27.14M | -28.09M |
| Total Depreciation and Amortization | 1.88M | 1.84M | 1.81M | 1.77M | 1.73M |
| Total Amortization of Deferred Charges | 223.00K | 200.00K | 199.00K | 228.00K | 255.00K |
| Total Other Non-Cash Items | 12.53M | 12.55M | 12.07M | 12.65M | 12.86M |
| Change in Net Operating Assets | -6.95M | -4.73M | -7.18M | -5.45M | -3.25M |
| Cash from Operations | -16.31M | -16.09M | -17.90M | -17.95M | -16.49M |
| Capital Expenditure | -274.00K | -344.00K | -239.00K | -306.00K | -299.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.00M | 3.50M | 6.80M | 9.30M | 10.80M |
| Cash from Investing | 1.73M | 3.16M | 6.56M | 8.99M | 10.50M |
| Total Debt Issued | 58.44M | 58.57M | -- | -- | -- |
| Total Debt Repaid | -60.51M | -60.51M | -- | -- | -- |
| Issuance of Common Stock | 72.03M | 74.99M | 75.37M | 5.21M | 12.71M |
| Repurchase of Common Stock | -50.14M | -50.11M | -50.01M | -881.00K | -826.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -186.00K |
| Cash from Financing | 19.81M | 22.95M | 25.36M | 4.33M | 11.69M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.23M | 10.01M | 14.02M | -4.63M | 5.70M |